Clinical Trial Update: SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update examining the SOX regimen (S-1 sequential therapy with oxaliplatin) for advanced biliary tract cancer and pancreatic cancer, spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Pancreatic Cancer
• Periampullary Adenocarcinoma

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Peking University | Conditions: Biliary Tract Cancer, Periampullary Adenocarcinoma | Phase 2 | Status: UNKNOWN